fda vertex pharmaceuticals

1st New Non-Opioid Painkiller in Decades Gets FDA Approval

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

MarketWatch · 5h

Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.

The Associated Press on MSN · 3h

FDA Approves First New Non-Opiod Painkiller in Decades

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

WWAY TV32m

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term ... from Wall ...

45m

Optimistic Outlook for Vertex Pharmaceuticals: Strong Performance, New Approvals, and Promising Pipeline Drive Buy Rating

Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...

Forbes Daily: DeepSeek’s AI Model Raises National Security Concerns

Friday's edition of Forbes Daily covers the investigation of the deadly plane crash, OpenAI's whopping valuation, sluggish ...

WISH-TV1h

Barnes and Noble credits growth to emergence of ‘BookTok’

Discover the latest trends in the business world, from Barnes and Noble's growth fueled by BookTok to the FDA's approval of a new nonopioid pain medication.

Investing1h

Apple, Exxon Mobil, AbbVie rise premarket; Chevron, Colgate-Palmolive fall

AbbVie (NYSE: ABBV) stock rose 4.2% after the drugmaker forecast 2025 profit above estimates, as strong sales of its newer ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results